Trial Profile
Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel in Patients Undergoing "One-stop" Hybrid Coronary Revascularization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Therapeutic Use
- 08 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
- 08 Feb 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Mar 2017.
- 05 Aug 2015 New trial record